Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-08

FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for risendronate sodium by Sun Pharmaceutical Industries, expanding or modifying its labeling under an existing appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISENDRONATE SODIUM (risendronate sodium)

Snippet

SUPPL AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)